Sterile injectable formulations of recombinant human insulin and analogs for subcutaneous delivery, produced by biopharmaceutical firms. Supplied to endocrinology clinics, hospitals, and retail pharmacies via medical distribution networks. Acquired by healthcare procurement teams for diabetes management in clinical settings.